Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)


Share Price
$ 1.90
Change
0.06 (3.26 %)
Market Cap
$90.14 m
Proactive Investors - Run By Investors For Investors

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company’s Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in the emergency treatment of acute allergic reactions,...

EPIC: ADMP
Market: NASDAQ:ADMP
52-week High/Low: $5.100 / $1.830
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $90.14 m
Website: www.adamispharmaceuticals.com
col 3
col 4
col 5
col 6

Adamis Pharmaceuticals Corporation Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use